G. Dalbasio et al., COMBINED THERAPY WITH 5-AMINOSALICYLIC ACID TABLETS AND ENEMAS FOR MAINTAINING REMISSION IN ULCERATIVE-COLITIS - A RANDOMIZED DOUBLE-BLIND-STUDY, The American journal of gastroenterology, 92(7), 1997, pp. 1143-1147
Objectives: To assess the efficacy of a combination of oral and topica
l 5-aminosalicylic acid (5-ASA) for the maintenance treatment of ulcer
ative colitis, we undertook a double-blind randomized clinical trial.
Methods: Patients aged 18 to 65 yr (with disease extent greater than p
roctitis only) were eligible for inclusion in the study if they met th
e following criteria: (a) history of two or more relapses in the last
gear; (b) achievement of remission in the last 3 months (with maintena
nce of remission for at least 1 month). Patients enrolled in the study
were randomly assigned to one of the two following l-yr treatments: (
1) combined therapy with 5-ASA tablets 1.6 g/day and 5-ASA enemas 3 g/
100 ml twice weekly; (2) oral therapy with 5-ASA tablets 1.6 g/day and
placebo enemas/twice weekly. The main end point of the study was the
maintenance of remission at 12 months. Results: Upon completion of the
study, relapse occurred in 13 of 33 patients in the combined treatmen
t group versus 23 of 36 patients in the oral treatment group (39 vs 69
%; p = 0.036). No significant side effects related to treatment were o
bserved in either group. A simplified pharmacoeconomic analysis shows
that this form of combined treatment can have a favorable cost-effecti
veness ratio. Conclusions: Our results indicate that 5-ASA given daily
by oral route and intermittently by topical route can be more effecti
ve than oral therapy alone. This form of combination treatment can be
appropriate for patients at high risk of relapse.